RESISTANCE (R) AND CROSS-RESISTANCE (XR) OF HUMAN OVARIAN-CANCER (OC) CELL-LINES TO ADRIAMYCIN (AD), MELPHALAN (ME) AND IRRADIATION (XRT)

被引：0
|
作者：
BEHRENS, BC [1 ]
LOUIE, KG [1 ]
HAMILTON, TC [1 ]
CURT, G [1 ]
KINSELLA, T [1 ]
YOUNG, RC [1 ]
OZOLS, RF [1 ]
机构：
[1] NCI,DIV CANC TREATMENT,BETHESDA,MD 20205
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1984年 / 25卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：336 / 336
页数：1
相关论文
共 50 条
  • [41] Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines
    ODwyer, PJ
    Perez, RP
    Yao, KS
    Godwin, AK
    Hamilton, TC
    [J]. BIOCHEMICAL PHARMACOLOGY, 1996, 52 (01) : 21 - 27
  • [42] BUTHIONINE SULFOXIMINE (BSO) REVERSAL OF X-RAY CROSS RESISTANCE IN DRUG-RESISTANT HUMAN OVARIAN-CANCER (OC) CELLS
    LOUIE, KG
    BEHRENS, BC
    KINSELLA, TJ
    HAMILTON, TC
    GROTZINGER, KR
    MCKOY, WM
    WINKER, MA
    YOUNG, RC
    OZOLS, RF
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 328 - 328
  • [43] INHERENT SENSITIVITY AND INDUCED RESISTANCE TO CHEMOTHERAPEUTIC DRUGS AND IRRADIATION IN HUMAN CANCER CELL-LINES - RELATIONSHIP TO MUTATION FREQUENCIES
    PARRIS, CN
    WALKER, MC
    MASTERS, JRW
    ARLETT, CF
    [J]. CANCER RESEARCH, 1990, 50 (23) : 7513 - 7518
  • [44] Cross-resistance of the gemcitabine resistant human ovarian cancer cell line AG6000 to standard and investigational drugs
    Bergman, AM
    Pinedo, HM
    van Haperen, VWTR
    Veerman, G
    Kuiper, CM
    Peters, GJ
    [J]. PURINE AND PYRIMIDINE METABOLISM IN MAN IX, 1998, 431 : 587 - 590
  • [45] Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines
    Vareki, Saman Maleki
    Salim, Kowthar Y.
    Danter, Wayne R.
    Koropatnick, James
    [J]. PLOS ONE, 2018, 13 (01):
  • [46] RADIATION SENSITIVITIES IN VARIOUS ANTICANCER-DRUG-RESISTANT HUMAN LUNG-CANCER CELL-LINES AND MECHANISM OF RADIATION CROSS-RESISTANCE IN A CISPLATIN-RESISTANT CELL-LINE
    OSHITA, F
    FUJIWARA, Y
    SAIJO, N
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1992, 119 (01) : 28 - 34
  • [47] DNA INTERSTRAND CROSS-LINKING AND DRUG SENSITIVITY TO CIS-DIAMMINEDICHLOROPLATINUM-II (CDDP) IN HUMAN OVARIAN-CANCER CELL-LINES INVITRO
    WARD, BG
    HILL, BT
    [J]. BRITISH JOURNAL OF CANCER, 1985, 51 (04) : 598 - 598
  • [48] INCREASED GENE-SPECIFIC REPAIR OF CISPLATIN INTERSTRAND CROSS-LINKS IN CISPLATIN-RESISTANT HUMAN OVARIAN-CANCER CELL-LINES
    ZHEN, WP
    LINK, CJ
    OCONNOR, PM
    REED, E
    PARKER, R
    HOWELL, SB
    BOHR, VA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (09) : 3689 - 3698
  • [49] Cross-resistance in the 2′,2′-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugs
    Bergman, AM
    Giaccone, G
    van Moorsel, CJA
    Mauritz, R
    Noordhuis, P
    Pinedo, HM
    Peters, GJ
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (15) : 1974 - 1983
  • [50] CHARACTERIZATION OF HIGH-LEVEL CISPLATIN-RESISTANT CELL-LINES ESTABLISHED FROM A HUMAN HEPATOMA-CELL LINE AND HUMAN KB ADENOCARCINOMA CELLS - CROSS-RESISTANCE AND PROTEIN-CHANGES
    SHEN, DW
    AKIYAMA, S
    SCHOENLEIN, P
    PASTAN, I
    GOTTESMAN, MM
    [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (04) : 676 - 683
12345